✦ LIBER ✦

Evaluation of Daclizumab to Reduce Delayed Graft Function in Non—Heart-Beating Renal Transplantation: A Prospective, Randomized Trial

✍ Scribed by C. Wilson; N.R. Brook; M.A. Gok; A. Gupta; J.F. Asher; M.L. Nicholson; D. Talbot

Book ID: 116931081
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 55 KB
Volume: 37
Category: Article
ISSN: 0041-1345
DOI: 10.1016/j.transproceed.2005.02.079

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Influence of delayed graft function in r

Influence of delayed graft function in renal transplants from cadaveric or non–heart-beating donors

✍ S.A White; S Jain; H Absalom; G Murphy; S.T Williams; A Knight; A.M Zickerman; M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Evaluation of the factors related to ear

Evaluation of the factors related to early graft function in 90 kidney transplants from non-heart-beating donors

✍ N. Matsuno; E. Sakurai; K. Kubota; K. Kozaki; M. Uchiyama; T. Nemoto; H. Degawa; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 224 KB

693: Everolimus in Longterm Heart Transp

693: Everolimus in Longterm Heart Transplanted Patients: Effects on Renal Function. One Year Results of a Prospective Randomized Trial

✍ R. Fiocchi; R. Sebastiani; A. Iacovoni; A. Fontana; A. Gamba 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Evaluation of renal function in liver tr

Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized clinical trial

✍ Eric M. Yoshida; Paul J. Marotta; Paul D. Greig; Norman M. Kneteman; Denis Marle 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Posttransplant chronic renal failure, secondary to calcineurin inhibitor agents, is emerging as a major problem in liver transplantation. We report a randomized clinical trial comparing daclizumab, delayed low-dose tacrolimus (target trough level 4-8 ng/mL, starting day 4-6), Investigational Arm (n

A randomized trial of basiliximab with t

A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function

✍ Amado Andrés; Roberto Marcén; Francisco Valdés; Jaime Sánchez Plumed; Ricard Sol 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 846 KB

469: Prospective, randomized, multicente

469: Prospective, randomized, multicenter trial comparing conversion to a CNI-free regimen (MMF & sirolimus) vs. a CNI-reduced, MMF-based immunosuppression to improve renal function in late cardiac transplant recipients

✍ J. Groetzner; U. Schulz; I. Kaczmarek; E. Stegemann; K. Kaiser; M. Voss; T. Witt 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB